We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Reducing Low-Value Health Services Encourages Savings

By HospiMedica International staff writers
Posted on 19 Sep 2016
Print article
A new study concludes that reducing spending on a wide array of low-value health services among insured adults holds considerable potential for cost savings.

Researchers at RAND Corporation (Pittsburgh, PA, USA) and the University of Southern California (USC; Los Angeles, USA) examined spending on 28 low-value healthcare services and procedures among U.S. adults (18 to 64 years of age) by reviewing more than 1.46 million commercial claims lodged at United Healthcare (UHC; Minnetonka, MN, USA) between 2011 and 2013. In all, 7.8% of the patients who put in claims received low-value services in 2013, with the total amount spent being USD 32.8 million, which accounted for 0.5% of total spending, or USD 22 per person annually.

The most commonly received low-value services included hormone tests for thyroid problems and imaging for low-back pain and uncomplicated headache. The greatest proportion of spending was for spinal injection for lower-back pain at USD 12.1 million, imaging for uncomplicated headache at USD 3.6 million, and imaging for nonspecific low-back pain at USD 3.1 million. Demographically, low-value spending was lower among patients who were older, male, black or Asian, lower-income, or enrolled on consumer-directed health plans, which have high member cost-sharing. The study was published as a research letter on August 29, 2016, in JAMA Internal Medicine.

“The services in this study reflect many clinical areas and types of care, but still are a small portion of all the low-value care patients receive. Our findings add evidence to the notion that reducing overuse of medical procedures could improve quality while reducing spending,” said lead author Rachel Reid, MD, of RAND. “The potential savings from reducing these low-value services and others are substantial.”

“Areas with high Medicare spending also seem to have greater use of low-value services among those with commercial insurance. This confirms that there are opportunities for cost savings, and that both private insurers and Medicare can benefit from efforts to reduce use of low-value care,” added senior author Professor Neeraj Sood, PhD, of USC. “Disparities in health care cut two ways -- it can cause poor access to high-value care among vulnerable patients and overuse of low-value care among more-advantaged groups. Both need attention.”

According to a 2012 report by the U.S. Institute of Medicine (IOM, Washington, DC, USA), more than USD 750 billion of health care spending annually represents waste, including approximately USD 200 billion in overtreatment. In order to reduce that amount, the American Board of Internal Medicine Foundation and consumer groups launched an initiative called ‘Choosing Wisely’ in order to encourage physicians and patients to engage in conversations about evidence-based medical practices.

Related Links:
RAND Corporation
University of Southern California
United Healthcare
U.S. Institute of Medicine
Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Bioengineered Collagen Implant
Tapestry Biointegrative Implant
New
Stereotactic QA Phantom
StereoPHAN

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.